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Background: tRNALys3 annealing to the viral RNA of human immunodeficiency virus type-1 (HIV-1) is an essential step
in the virus life cycle, because this tRNA serves as the primer for initiating reverse transcription. tRNALys3 annealing to
viral RNA occurs in two steps. First, Gag promotes annealing of tRNALys3 to the viral RNA during cytoplasmic HIV-1
assembly. Second, mature nucleocapsid (NCp7), produced from the processing of Gag by viral protease during viral
budding from the cell, remodels the annealed complex to form a more stable interaction between the viral RNA and
tRNALys3, resulting in a more tightly bound and efficient primer for reverse transcription.
Results: In this report, we have used in virio SHAPE analysis of both the 5´-untranslated region in HIV-1 RNA and the
annealed tRNALys3 to determine structural differences of the annealed complex that occur between protease-negative
(Pr-) and wild type viruses. Our results indicate that the weaker binding of tRNALys3 annealed by Gag in Pr- virions
reflects both missing interactions of tRNALys3 with viral RNA regions in the upper PBS stem, and a weaker interaction
with the internal stem-loop found within the unannealed primer binding site in viral RNA.
Conclusions: We propose secondary structure models for the tRNALys3/viral RNA annealed complexes in PR- and wild
type viruses that support the two-step annealing model by showing that Gag promotes a partial annealing of tRNALys3
to HIV-1 viral RNA, followed by a more complete annealing by NCp7.
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Following infection of a host cell by HIV-1, the viral
RNA genome (vRNA) is reverse transcribed into a
double-stranded DNA, which then integrates into the
host cell’s genome. Reverse transcription is initiated
from a primer tRNALys3 that was previously annealed
during viral assembly to an 18 nt sequence in the viral
RNA termed the primer binding site (PBS). The 18 nt
PBS (nt 182–199) is found immediately downstream of
the unique 5´ (U5) region in viral RNA, and is comple-
mentary to the 3´ terminal 18 nt of tRNALys3. Annealing
to the PBS sequence is required for tRNALys3 annealing
[1–3]. Two other regions in the 5´-untranslated region
(5´-UTR) upstream of the PBS, the poly(A) loop and the
C-rich region, have also been implicated in interacting* Correspondence: lawrence.kleiman@mcgill.ca
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unless otherwise stated.with complementary sequences in the 3´-half of tRNALys3.
They were first proposed in the case of an HIV-1 MAL
isolate that belongs to sub-type A by Marquet group
[4, 5]. While the presence of these interactions in sub-type
B isolates (HXB2 and NL4.3) was controversial [6], the
Weeks group was able to detect these additional interac-
tions in wild type virions using SHAPE [7]. An additional
viral RNA sequence upstream of these sequences, termed
the primer activation site (PAS), was also reported to inter-
act with complementary sequences in the 5´-half of the
TΨC arm [8] in tRNALys3, but this interaction appears to
occur only during the initiation of reverse transcription [9].
The annealing of tRNALys3 to viral RNA is a multi-step
process, promoted by both the viral Gag precursor, and
later, after viral protein processing, by mature nucleocap-
sid (NCp7). tRNALys3 annealing to viral RNA in vitro at
37 °C does not occur at a wide range of RNA concentra-
tions unless either Gag or NCp7 is present [10, 11].
Furthermore, specific mutations within nucleocapsidis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Fig. 1 Gag processing in wild type and Pr- viral particles. Wild type
and Pr- viral particles produced from transfected 293 T cells were lysed,
and a Western blot of the viral lysates was probed with anti-CAp24, as
described in Methods
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in protease-negative viruses up to 80 %, independently of
any effect such mutations might have on viral genomic
RNA packaging [12]. Gag promotes the first step in an-
nealing within a cytoplasmic annealing complex repre-
senting an early HIV-1 assembly intermediate, whose
composition includes Gag, GagPol, lysyl-tRNA synthetase
(LysRS), viral RNA, and tRNALys3 [13]. The binding of
both lysyl-tRNAs and non-lysyl tRNAs to this complex
takes place prior to budding, and most likely at the site of
translation of viral proteins, since the relative concentra-
tion of non-lysyl tRNAs in the virus match the codon
usage of viral mRNA, not cellular mRNA [14, 15]. How-
ever, The concentration of tRNALys relative to non-lysyl
tRNAs is also increased 8–10 fold over that in the cyto-
plasm due to a specific interaction of Gag with the major
tRNALys binding protein, lysyl-tRNA synthetase [13].
Compared to NCp7-annealed tRNALys3, Gag-annealed
tRNALys3 has a 2/3 reduced ability to initiate reverse
transcription [16], and binds more weakly to viral RNA
[17]. Thus, using total viral RNA extracted from wild
type (Pr+) or protease-negative (Pr-) viruses, the weaker
binding of tRNALys3 was shown by the ability of an
in vitro reverse transcript from a primer upstream of the
primer binding site to displace tRNALys3 annealed by
Gag in a Pr- virus, but unable to displace tRNALys3
annealed by NCp7 in a Pr+ virus. Furthermore, in that
report, we showed that weaker binding to viral RNA,
and the reduced ability of Gag-annealed tRNALys3 to
function as a primer for reverse transcription, can be
rescued by a transient exposure to purified NCp7 of
total viral RNA isolated from Pr(−) virions [17]. This
suggests that while Gag may initially anneal tRNALys3 to
the viral RNA, after viral protein processing, which may
occur during or after viral budding [18], exposure of the
annealed complex to NCp7 may fine-tune the annealed
tRNALys3 to produce an annealed tRNALys3 that will
function more efficiently as a primer.
The aim of this study is then to elucidate the struc-
tural differences between Gag- and NCp7-mediated
tRNALys3 annealing within the viral particle. To examine
how tRNALys3 anneals to HIV-1 RNA, we compared the
structural interactions that occur between tRNALys3 and
viral RNA in protease-negative (Pr-) and wild type (Pr+)
virions, using in virio SHAPE (selective 2´-hydroxyl acyl-
ation analyzed by primer extension). This method was
developed by the group of K. Weeks [19], and used to
predict the secondary structure of the annealed
tRNALys3/viral RNA complex in wild type virions, based
upon the reactivity of individual nucleotides (nts) in the
viral RNA with the acylating agent NMIA (N-methyliso-
toic anhydride). NMIA reacts with the ribose 2´-hy-
droxyl group in flexible, unpaired, nucleotides. In this
work, we have used SHAPE to measure the reactivitytoward NMIA of nts in both viral RNA and annealed
tRNALys3, within both Pr- and wild type virions. Our re-
sults indicate that the weaker binding of tRNALys3
annealed by Gag in Pr- virions reflects missing interac-
tions of tRNALys3 with the upper PBS stem, and an al-
tered interaction of tRNALys3 with the internal stem
loop found within the unannealed PBS sequence.
Results
In virio SHAPE reactivities of the 5´-UTR from wild type
and protease-negative HIV-1
Extracellular wild type BH10 (Pr+) and protease-negative
BH10-Pr- (Pr-) were produced from transfected 293 T
cells, and purified on a sucrose-gradient as described in
Methods. Figure 1 shows a Western blot of viral lysate
probed with anti-CAp24, and verifies the absence of Gag
processing in Pr- virus. The viral RNA was modified
within the intact viral particles by NMIA, and then ex-
tracted from the viral particles. The reactivity toward
NMIA at each nucleotide (nt) position was determined
by SHAPE. The average reactivity at each position and
the standard deviations were calculated for nucleotides 5
to 348, using three independent experiments for both
wild type and Pr- viral RNA. Nucleotides (nts) 1 to 4
and 349 to 406 were not analyzed due to ambiguous
alignment at the 5´ and 3´ ends of the RNA. We refer to
nts 5–348 as the 5´ untranslated region (5´-UTR) of the
viral RNA, although it also includes the first 14 nts cod-
ing for Gag. In Fig. 2a, we show the secondary structure
of wild type 5´-UTR predicted using the program RNAs-
tructure, which combines nt reactivities obtained using
in virio SHAPE with the proposed best thermodynamic-
ally stable structures, as described in Methods. The sec-
ondary structure model is similar to the previously
published model for wild type HIV-1 by Weeks’s group
[20], with a minor difference being that the U5:AUG
stem is extended by three additional base pairings in our
Fig. 2 Secondary structure of the HIV-1 5´-UTR in wild type and Pr- HIV-1. (a) Secondary structure model for HIV-1 wild type 5´-UTR. The secondary
structure model was built using RNAstructure software based on the reactivities determined in this study. The low reactivities seen for nucleotides G79
to C85 (grey box) were proposed to result from an interaction with downstream sequences G443 to C449 [19]. Similarly, The low reactivities of the
grey-boxed nucleotides in the DIS loop (nts 257–262) have been proposed to result from pairing with a homologous viral RNA molecule in the viral
RNA dimer. The AUG start codon is boxed in black. (b) The difference in SHAPE reactivities of Pr- viral 5´-UTR relative to the reactivities of wild
type 5´-UTR. The difference in SHAPE reactivities between Pr- and wild type 5´-UTRs were calculated by subtracting the sum of the standard
deviations at each nt position from the absolute value of the difference of reactivities at every position for each data set (|(reactivityPr-)-(reactivitywt)|-
(StdPr- + Stdwt)). A zero value was assigned to positions where the result was negative, implying that the error is higher than the difference in
reactivities. Positive values indicate that the reactivity toward NMIA at the specified nucleotides is higher in the Pr- virions. The calculations and the
graph plot were drawn using Excel from the Microsoft Office Package
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viral RNA shown in Fig. 2a, while derived from our re-
activity data, is based on a previously proposed model
for how tRNALys3 interacts with the viral RNA [19]. In
addition to the PBS, tRNALys3 will also bind to two other
regions in the upper PBS stem of viral RNA, termed theC-rich and poly(A) loop regions. SHAPE reactivities and
the predicted secondary structure model of the 5´-UTR
within Pr- viruses are similar to those of wild type vi-
ruses, except in the regions that include the upper PBS
stem and the PBS loop (see Fig. 2a). This is shown in
Fig. 2b, in which the SHAPE reactivities of Pr- viral 5´-
Seif et al. Retrovirology  (2015) 12:40 Page 4 of 10UTR are plotted relative to the reactivities of wild type
5´-UTR.
Structural differences within the viral RNA/tRNALys3
annealed complex
To better understand the significance of the observed
differences in reactivities shown in Fig. 2b in the context
of tRNALys3 annealing, we compared in virio SHAPE re-
activities in these regions for wild type and Pr- virions
with the SHAPE reactivities of an unannealed in vitro
transcribed 5´-UTR of HIV-1. We previously described
the production and characteristics of this construct [20].
Figure 3 shows the individual SHAPE reactivities for
each nucleotide in these regions, while Fig. 4 shows sec-
ondary structure models of the PBS stem-loop regions
predicted using the RNAstructure program for the
unannealed in vitro transcribed 5´-UTR, and viral RNAsFig. 3 The SHAPE reactivities for regions of annealing in the HIV-1 5´-UTR.
(white), and viral RNA found in Pr- (grey), and wild type (black) viral particle
to 170, and (c) nts 182 to 199. The results shown are the averages of three
errors shown in the graph correspond to the standard deviations calculatefound in Pr- and wild type virions. The unannealed PBS
sequence itself contains an internal stem loop, and other
nucleotides with low reactivities within the larger PBS
loop suggest some tertiary interactions that constrain
the flexibility of these nucleotides. As seen in Figs. 3c
and 4c, all of the PBS nucleotides show relatively low
SHAPE reactivity in the annealed viral RNA from wild
type viruses (Figs. 3c and 4b). In RNA from the Pr- virus
significantly higher reactivities can be seen for internal
loop nucleotides 191 and 192, suggesting a less efficient
annealing of tRNALys3 to these sequences by Gag. Nucle-
otides 193 and 194 show low reactivities in unannealed,
Pr-, and Pr + RNAs, and the differences between all
three samples are not significant. These nucleotides are
probably stabilized in a conformation unfavorable for
modification by NMIA, even if they are not involved in
a Watson-Crick base pair. In Fig. 4b, we propose aSHAPE reactivities for in vitro transcribed unannealed HIV-1 5´-UTR
s are shown for sequences containing (a) nts 144 to 146, (b) nts 167
readings at each nucleotide position for 5´-UTR, Pr- and wild type. The
d at each nucleotide position
Fig. 4 Models for tRNALys3 binding to regions of annealing in the HIV-1 5´ UTR, based on the reactivities shown in Fig. 3. Secondary structure models
of the PBS stem-loop from (a) in vitro transcribed unannealed HIV-1 5´-UTR, and from RNA present in (b) Pr- and (c) wild type virions. Only sequences
of tRNALys3 involved in the annealing to viral RNA are shown in the figures
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ing the observed SHAPE reactivities. To verify that the
decrease in reactivities of nucleotides 183 and 184 within
the PBS sequence of the Pr- viral RNA does not result
from tRNALys3 annealing in the absence of Gag, we in-
cubated in vitro transcribed 5´-UTR viral RNA and
tRNALys3 (1 to 10 ratio) in the absence of Gag for
30 min at 37 °C, and performed SHAPE experiments.
The reactivities within the PBS sequence remained simi-
lar to that of unannealed 5´-UTR RNA (see Additional
file 1).
As shown in Figs. 3a,b and 4c, the upper PBS stem in
the viral RNA includes two additional sites that interact
with the tRNALys3. The first includes nts C142-A147 and
is referred to as the C-rich region (Figs. 3a and 4). In
unannealed viral RNA, these nts show low reactivities, as
they are part of the upper PBS stem. Similar low reactiv-
ities are found in this region in viral RNA from wild type
viruses, since the C-rich region interacts with part of the
variable loop and anticodon stem of tRNALys3 (Fig. 4c).
However, as shown in Fig. 3a, three nts (144–146) of Pr-
mutant show an increase in reactivities compared to either
unannealed viral RNA or viral RNA from wild type vi-
ruses, suggesting a weaker interaction in this region. The
second interacting site in viral RNA includes nts G167-
A170 and is referred to as the poly(A) loop. This site inter-
acts with the U-rich anticodon loop of tRNALys3. Nts 168
and 170 show higher reactivities in the Pr- mutant than inwild type virus (Fig. 3b). These observations suggest that
the interactions between tRNALys3 and vRNA are also
weakened in the Pr- virus. To verify that the observed dif-
ferences result from tRNA/vRNA interactions and not
from differences in RNA-protein interactions, we have
treated both Pr + and Pr- viral particles with proteinase K
prior to RNA modification using NMIA (ex virio) and per-
formed SHAPE analysis. The complete data sets are
shown in Additional file 2. Several changes in reactivities
were observed in the upper PBS stem and the PBS loop
(nts 130 to 217). For Pr+, changes occurred at nucleotides
136,137,147, 151, 156, 172, 178, 180, 181, 203, 206 and
207. For Pr-, changes occurred at nucleotides 137, 141,
156, 157, 159, 166, 171, 172, 177, 181, 182, 200, 203 and
204. However, the results presented in Additional files 3
and 4 show that ex virio and in virio shape reactivities are
similar for the nucleotides we analyzed to establish our
hypothesis, and support our assumption that the observed
changes between Pr + and Pr- are due to an altered
tRNALys3 annealing to viral RNA.
SHAPE analysis of annealed tRNALys3 in virio
Our conclusions thus far concerning the interactions oc-
curring between viral RNA and tRNALys3 are based
solely on SHAPE analysis of viral RNA. To investigate
the validity of these conclusions, we also determined the
SHAPE reactivities of the annealed tRNALys3 within wild
type and Pr- viral particles. In this procedure, we
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using columns that retain only RNAs larger than 200 nts
after extracting the NMIA-modified RNA from the viral
particles. The annealed tRNAs were released from the
viral genomic RNA by heating to 70 °C for 5 min, and
poly(A) tails were added to the tRNA as described in
Methods. The reverse transcription was primed by an
oligomer specific to tRNALys3 at the 3´ end. As shown in
Fig. 5, SHAPE reactivities were determined for nts 7–55
of the tRNA. The reactivities for nucleotides 1 to 6 and
55 to 76 were not determined because the primer used
for the primer extension reaction includes the 3´ ter-
minal nucleotides of the tRNA, and because the se-
quence alignment close to the 5´ and 3´ ends is
ambiguous. Consequently, SHAPE reactivities for the 3´
terminal 18 nts of tRNALys3, the sequence that binds to
the PBS, could not be calculated. For comparative stud-
ies we also determined SHAPE reactivities of an in vitro
transcribed tRNALys3. Several stops were noticed in the
modified and the unmodified reverse transcription reac-
tions of the in virio tRNAs from wt and Pr- viral parti-
cles, but not in the in vitro transcribed tRNA. These
stops correspond to modified nucleotides 10, 16, 20, 37,
47, and 53. These nucleotides were marked as notFig. 5 (a) SHAPE reactivities of the in vitro transcribed tRNA are shown on
implicated in annealing to viral RNA. SHAPE reactivities of tRNALys3 nts invo
(c) for the anti C-rich region. Reactivities from unannealed in vitro transcrib
white, grey and black respectively. The results shown are the averages of th
standard deviations calculated at each nucleotide positionanalyzed. They are shown in grey in the figures, and
given a −999 value in the reactivities datasets (see
Additional file 2).
The region including nucleotides U33-U36, which is
part of the anticodon loop in annealed tRNALys3, is
referred to in Fig. 5 as the anti-poly(A) loop, because it
interacts with the poly(A) loop of viral RNA. The anti-
poly(A) loop region from annealed tRNALys3 in wild type
virions is non-reactive to NMIA, indicating that it is
annealed in these virions (Fig. 5). However, for annealed
tRNALys3 from Pr- viruses and for the in vitro tran-
scribed tRNA, U34 and U35 retain low reactivities
(<0.2), while U33 and U36 have high reactivities (see
Fig. 5). This would suggest that U34 and U35 adopt a
conformation that inhibits their modification by NMIA,
although we cannot exclude the possibility of an inter-
molecular pairing. In Fig. 4b, we see that in the poly(A)
area within viral RNA, the G167 that could have paired
with the highly reactive tRNALys3(U33) has in fact low
reactivity, presumably because it forms a base pair
within the viral stem. Similarly, the low reactivity of
tRNALys3(U34) coupled with the high reactivity of A168
in viral RNA also suggests that these two nts are not
base- paired, and that the low reactivity of tRNALys3(U34the secondary structure model of tRNALys3. Boxed nucleotides are
lved in annealing are shown in (b) for the anti-poly(a) region, and in
ed tRNA, annealed tRNA from wild type and Pr- virions are shown in
ree readings at each nucleotide position. The errors correspond to the
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modification as discussed above. Low reactivities for
both tRNALys3(U35) and vRNA(A169) suggest a possible
base pair, but the high reactivities of both A170 in viral
RNA and U36 in tRNALys3 suggest the absence of base
pairing. Thus, 3 of the 4 potential base pairs in this re-
gion of interaction between viral RNA and tRNALys3 are
absent in the Pr- virus.
Low reactivities in the C-rich region of viral RNA
(nts 142–147) could result from maintaining the upper
PBS stem, or could result from annealing with a com-
plementary region in tRNALys3, referred to in Fig. 5 as
the anti-C-rich region (tRNALys3 (41–46)). U145 is the
only nucleotides that would be free if the annealing is
weakened or does not occur (see Fig. 4a). As expected
by our conclusions, the nucleotides U145 show a sig-
nificant increase in reactivity in the Pr- viral RNA
(Fig. 3a). In support of this interpretation, we find that
nts 41–46 in tRNALys3 do have low reactivity, i.e., are
base-paired. However in Pr-, one out of six nucleotides
from the anti-C-rich region of the tRNA show high re-
activities, 1.1 for A43 (Fig. 5). The limited increase in
reactivities for the Pr- results from the alternative
structure that the unannealed regions would adopt.
These observations support the conclusion that in Pr-
mutant, tRNALys3 annealing to the upper PBS stem is
missing.
Discussion
Previous studies have indicated that tRNALys3 annealed
either by Gag in vitro, or within a Pr- virus, is less tightly
bound to the viral genomic RNA, and is a less efficient
primer for reverse transcriptase, than tRNALys3 annealed
either in vitro with mature nucleocapsid (NCp7) or in
wild type viruses [17, 18]. We used in virio SHAPE ana-
lysis to investigate these differences while inducing min-
imal changes in the RNA structure during isolation of
RNA from viruses. The results reported here show struc-
tural differences within the tRNALys3/viral RNA complex
isolated from wild type or Pr- viruses that correlate with
these findings. Although some positions show high
standard deviations, all our experiments were repeated
three times independently, and showed a similar trend
in all cases. The proposed models are further supported
by the changes in NMIA reactivities occurring only in
the interacting regions of viral RNA and the tRNALys3
(Figs. 2b, 3 and 4), i.e. on the complementary strands of
the upper PBS stem, and between the viral RNA and the
complementary region in the tRNA. Our models corrob-
orate earlier observations showing that annealing is
weaker in protease-negative virions than in wild type vi-
rions (17, 18). Our results indicate that the weaker bind-
ing of Gag-annealed tRNALys3 results from a poor ability
of Gag to anneal tRNALys3 sequences to the internalloop present within the unannealed PBS sequence, and
to the C-rich and poly(A) regions in viral RNA upstream
of the PBS that are also involved in annealing in wild
type viruses. SHAPE reactivities obtained for both the
annealed regions in viral RNA and the C-rich and poly(A)
regions of annealed tRNALys3 were found to be comple-
mentary, but for technical reasons, the SHAPE reactivities
of the 3´-terminal 18 nts of tRNALys3 could not be obtained
and compared with the PBS SHAPE reactivities.
In this work, the differences in acylation sensitivity
found in Pr + and Pr- samples is assumed to reflect dif-
ferences in RNA backbone structure, and not different
abilities of protein bound to the RNA to inhibit or
promote access to the acylation reagent. To support this
assumption, we performed SHAPE analysis on de-
proteinized Pr + and Pr- viral RNA, and found that the
nucleotides we analyzed did not show any significant dif-
ference in SHAPE reactivity in absence or presence of
the proteins. In fact, the effect of proteins on NMIA
modification was previously studied by Kevin Weeks’s
group for the first 5´- 990 nts of the HIV-1 genome, and
done both in virio and ex virio [19], SHAPE reactivity
patterns for the in virio and protein-free ex virio states
were very similar for the major length of the viral RNA.
They also examined more specifically the effect of NCp7
binding on SHAPE reactivities in virio by exposing vi-
rions to a reagent that inhibited NCp7 binding to the
viral RNA. They found distinct regions in the viral RNA
that bound to NCp7, which depending upon the nature of
the binding, could cause increases or decreases in NMIA
reactivity of individual nts. However, none of the nts dem-
onstrated here to be involved in tRNALys3 annealing
showed binding to NCp7 in their study, and in fact, these
nts showed similar reactivities to NMIA both in virio and
ex virio. Furthermore, to support our interpretation of the
changes observed, we have shown that changes in NMIA
reactivities noticed in the annealing areas on the viral RNA
are accompanied by similar changes in the complementary
nucleotides on the tRNALys3 molecule.
The inability of Gag to anneal tRNALys3 to regions in
viral RNA upstream of the PBS may be due to a limited
ability of nucleocapsid sequence within Gag to denature
RNA duplexes. It has been observed previously that Gag
and mature NCp7 destabilize RNA structures in different
propensities [21, 22]. NMR studies have shown that NCp7
protein has a dynamic structure that helps binding to nu-
cleic acids with different sequence and structure [23], and
that the conformation of nucleocapsid sequence within
Gag could be influenced by the overall Gag conformation.
For example, the matrix (MA) domain in Gag has been
shown to modulate Gag’s nucleic acid chaperone activity
via binding to inositol phosphate (IP) in the membrane
[24]. In absence of IP, the MA domain inhibits Gag’s tRNA
annealing capacity. NC’s conformation and annealing
Seif et al. Retrovirology  (2015) 12:40 Page 8 of 10ability could also be limited by its local interaction with
neighboring Gag sequences.
While nucleocapsid sequences within Gag can pro-
mote a relatively weak interaction of the terminal 18 nts
of tRNALys3 with the PBS in viral RNA, it appears that
only mature NCp7 promotes the interactions of two
regions within the anticodon stem-loop of tRNALys3 with
nucleotides 142–147 and 167–170 of the upper PBS
stem. The in vitro interaction of NCp7 with tRNALys3
has been shown to destabilize the acceptor stem, the
T-stem-loop, and the anticodon stem-loop [25, 26], and
it would be of interest to determine if Gag is able to
destabilize the anticodon stem-loop as efficiently as
NCp7.
The difficulty of bringing cytoplasmic tRNALys3 to an
18 nt PBS sequence within a structurally complex >9 kb
viral genomic RNA may explain the need for a multistep
annealing mechanism, even if the initial cytoplasmic
binding of the tRNALy3 to viral RNA is weak relative to
annealing by mature NCp7. An early cytoplasmic HIV-1
assembly intermediate composed of unprocessed Gag
and GagPol and viral RNA will promote this initial
annealing through its molecular organization [13], its
ability to selectively concentrate tRNALys3 at the cyto-
plasmic site of viral assembly through a specific Gag/
LysRS interaction [27], and its selective binding to
RNA sequences close to the PBS [23, 28]. These
properties of this complex will be lost upon viral pro-
tein processing.
The cytoplasmic annealing of tRNALys3 to viral RNA by
Gag appears to serve another function in addition to pre-
paring tRNALys3 to act as a primer for reverse transcrip-
tion. Thus, it has been reported that annealing of
tRNALys3 to the PBS aids in promoting a conformation
change in the 5´-untranslated region of viral RNA that
promotes viral RNA dimerization [11, 20], a process re-
quired for efficient incorporation of viral RNA into the
virus [29, 30].
Conclusions
In conclusion, our study confirms the findings that in
wild type HIV-1 subtype B virions, interactions occur
between tRNALys3 and the upper PBS stem. We also
found major differences in the interactions between viral
RNA and annealed tRNALys3 from Pr- and wild type vi-
rions. These differences reveal the reasons why annealed
tRNALys3 is less tightly bound in Pr- virions. These find-




SVC21.BH10 is a simian virus 40-based vector that
codes for the wild type sequence of HIV-1 proviral DNA[31]. The protease-deficient mutant (Pr-) is an
SVC21.BH10 plasmid coding for an inactive protease
with an Asp25 to Arg25 mutation [32].
Viral particle production and modification by NMIA
For each SHAPE reading, 24 cell culture plates (15 cm
diameter) were inoculated with 6 million HEK 293 T
cells per plate and grown in complete Dulbecco’s modi-
fied Eagles’s medium (DMEM). After overnight incuba-
tion, the cells were transiently transfected by wild type
BH10 or BH10 Pr- plasmids using lipofectamine 2000
from Invitrogen according to the manufacturer’s recom-
mendations. The supernatant was collected 48 h post-
transfection, and filtered through 0.2 μm filters. The
viral particles were pelleted in a Beckman Ti-45 at 35
000 rpm for 1 h. The pellets were then purified by 15 %
sucrose onto a 65 % sucrose cushion by centrifugation in
SW41 rotor at 26 500 rpm for 1 h. The layer of purified
viral particles was collected and the virus was pelleted
using Beckman SW41 rotor at 35 000 rpm for 1 h, in 1X
TNE buffer (20 mM Tris–HCl pH 7.8; 100 mM NaCl,
1 mM EDTA). The viral particles were resuspended in
600 μl of NMIA reaction buffer (50 mM Hepes pH 8,
200 mM NaCl, 0.1 mM EDTA, and 10 % fetal bovine
serum), and modified using NMIA for 50 min at 37 °C as
described in [19]. For ex virio analysis, the viral particles
were treated with proteinase K for 30 min at 37 °C prior
to treatment with NMIA.
Western blot
Prior to modification with NMIA, 2 % of the viral parti-
cles were mixed with protein gel loading dye (2X; 4 %
SDS, 20 % glycerol, 10 % 2-mercaptoethanol, 0.004 %
bromophenol blue and 0.125 M Tris HCl, pH 6.8), lysed
by boiling, and run on a 10 % SDS-PAGE gel. Following
gel transfer by electroblotting, the membrane was
probed with mouse anti-CAp24 antibody (NIH AIDS
Research and Reference Reagent Program).
RNA purification and SHAPE analysis
The modified and control (unmodified) viral particles
were lysed with 1 % SDS and Proteinase K treatment
at room temperature for 20 min, followed by a phenol
extraction as proposed by [19]. The RNA was purified
from the lysate and concentrated using RNA clean &
Concentrator-5 from Zymoresearch (Cat. #R1015).
Equal amounts of RNAs (1 ρmole) were used for wild
type and protease negative mutant. The RNA was re-
verse transcribed using Superscript III Reverse Tran-
scriptase kit from Invitrogen (Cat. #18080-044), and a
primer complementary to BH10 wild type sequences,
nucleotides 382 to 406, labeled with VIC-fluorescent dye
from Applied Biosystems (5´ VIC-CCTGGCCTTAACC-
GAATTTT TTCC 3´). The reactions were purified on
Seif et al. Retrovirology  (2015) 12:40 Page 9 of 10Sephadex G-50 columns, ethanol precipitated, and
resuspended in water. The ladder was prepared from
purified unmodified viral RNA as previously de-
scribed [20].
The products were resolved by capillary electrophor-
esis at the IRIC (Institut de Recherche en Immunologie
et Cancérologie) genomic center. The data were ana-
lyzed and normalized as described in [20, 33] using
peakScanner (freely available from ABI), FAST software
(freely provided by the Jeffrey Glenn laboratory), and
RNAStructure (freely provided by Dr. David Mathews la-
boratory). The unannealed RNA was produced by
in vitro transcription from a BH10 template, and was an-
alyzed by SHAPE as described previously [20].SHAPE analysis of annealed tRNALys3
The viral particles were produced and treated with
NMIA as described for viral RNA. Following viral
lysis, the RNA was treated with acidic phenol, and the
aqueous phase was purified using Clean and Concen-
trate kit in conditions that retain RNAs larger than
200 nucleotides. The RNAs were heated to 70 °C for
5 min and then chilled on ice. Following a short spin
at 12 000 rpm, the RNAs were treated with poly(A)
polymerase using poly(A) tailing kit from Ambion
(Cat# AM1350). The mix was treated with phenol, and
the aqueous phase was purified on RNA clean and
concentrate columns in conditions were RNAs larger
than 17 nucleotides are retained. tRNALys3 was reverse
transcribed as described for viral RNA in presence of
VIC fluorophore labeled oligomer that includes 6 nu-
cleotides specific to tRNALys3 and a poly U tail, 5´
VIC-TTTTTTTTTTTTTTTTGGCGCCCG 3´. The
reverse transcription reaction was purified on Sepha-
dex G25 column, ethanol precipitated, resuspended in
water, and analyzed by capillary electrophoresis as de-
scribed for viral RNA. The tRNALys3 ladder used for
performing SHAPE analysis, was produced by sequen-
cing a DNA template coding for tRNALys3 with a
poly(A) tail, the same oligomer used for SHAPE ana-
lysis, and Sequenase™ version 2.0 DNA sequencing kit
from USB (cat # 70770 1kt) according to the manufac-
tuer’s recommendations for short readings.SHAPE analysis of unannealed 5´UTR in presence of non
denatured tRNALys3
Three pmoles of in vitro transcribed 5´-UTR were in-
cubated with thirty pmoles of tRNALys3, without heat
denaturation, at 37 °C for 30 min, in 10 mM HEPES
pH 8.0, 1 mM MgCl2, 10 mM NaCl, 150 mM KCl.
SHAPE experiments were performed on the 5´-UTR
RNA as described above.Additional files
Additional file 1: Comparison of SHAPE reactivities for viral RNA
nucleotides 182-199 from 5´-UTR RNA, 5´-UTR RNA + tRNALys3, and Pr-
virions. SHAPE reactivities for in vitro transcribed unannealed HIV-1 5´-UTR
(white), unannealed 5´-UTR + tRNALys3 (grey), and viral RNA found in Pr-
(black) viral particles are shown for nucleodtides 182 to 199. The results
shown are the averages of three readings at each nucleotide position. The
errors shown in the graph correspond to the standard deviations calculated
at each nucleotide position. The complete data sets are found in Additional
file 2.
Additional file 2: Complete data sets of SHAPE reactivities.
Complete data sets of SHAPE reactivities and the corresponding standard
deviations for in virio Pr+, Pr-, and in vitro transcribed 5´UTR viral RNA in
sheet 1; tRNALys3 from Pr + and Pr- viral particles and in vitro transcribed
tRNALys3 in sheet 2, and ex virio Pr + and Pr- viral RNA in sheet 3.
Additional file 3: Comparison of SHAPE reactivities for tRNALys3
annealing sequences of Pr- viral RNA from intact (in virio) and
proteinase K-treated viral particles (ex virio). For in virio (grey), intact
viral particles were treated with NMIA to modify the viral RNA within the
viral particle, whereas for ex virio (white), the viral particles were treated
with proteinase K prior to addition of NMIA. SHAPE reactivities for
nucleotides (A) 144 to 146, (B) 167 to 170, and (C) 182 to 199, from wt
viral RNA are shown.
Additional file 4: Comparison of SHAPE reactivities for tRNALys3
annealing sequences within Pr + viral RNA from intact (in virio) and
proteinase K-treated viral particles (ex virio). For in virio (grey), intact
viral particles were treated with NMIA to modify the viral RNA within the
viral particle, whereas for ex virio (white), the viral particles were treated
with proteinase K prior to addition of NMIA. SHAPE reactivities for
nucleotides (A) 144 to 146, (B) 167 to 170, and (C) 182 to 199, from wt
viral RNA are shown.Competing interests
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